412402004: Hepatitis B virus recombinant vaccine (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2467854015 Hepatitis B virus recombinant vaccine (substance) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core

2473980018 Hepatitis B virus recombinant vaccine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

3267761000005111 rekombinant vaccine mod hepatitis B-virus da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
rekombinant vaccine mod hepatitis B-virus	Is a	vaccine mod hepatitis B-virus	false	Inferred relationship	Some
rekombinant vaccine mod hepatitis B-virus	Is a	Drug allergen	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
rekombinant hepatitis B-virus-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	rekombinant vaccine mod hepatitis B-virus	Inferred relationship	Some	1
hepatitis B-virus-vaccine, rekombinant, 10 µg/0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	rekombinant vaccine mod hepatitis B-virus	Inferred relationship	Some
Hepatitis b virus vaccine re 10mcg/0.5 mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	rekombinant vaccine mod hepatitis B-virus	Inferred relationship	Some
Hepatitis b virus vaccine re 10mcg/.5mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	rekombinant vaccine mod hepatitis B-virus	Inferred relationship	Some
hepatitis B-vaccine, rDNA, injektionsvæske 20 µg/ml 0,5 ml i fyldt sprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	rekombinant vaccine mod hepatitis B-virus	Inferred relationship	Some
Haemophilus influenzae type b + rekombinant hepatitis B-virus-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	rekombinant vaccine mod hepatitis B-virus	Inferred relationship	Some	2
Haemophilus influenzae type b 7,5 µg + rekombinant hepatitis B-virusoverfladeantigen 5 µg injektionsvæske, opløsning, hætteglas a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	rekombinant vaccine mod hepatitis B-virus	Inferred relationship	Some
rekombinant hepatitis B-virusoverfladeantigenvaccine 10 µg + difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulær kighostevaccine 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	rekombinant vaccine mod hepatitis B-virus	Inferred relationship	Some
Haemophilus influenzae type b-vaccine 10 µg + difteritoxoid 30 IE + tetanustoxoid 40 IE + kighostevaccine 25 µg + rekombinant hepatitis B-virusoverfladeantigenvaccine 10 µg + inaktiveret poliovaccine injektionsvæske, opløsning 0,5 ml i fyldt sprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	rekombinant vaccine mod hepatitis B-virus	Inferred relationship	Some
difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	rekombinant vaccine mod hepatitis B-virus	Inferred relationship	Some	3
difteri- + tetanus- + kighoste- + polio- + rekombinant hepatitis B-virus-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	rekombinant vaccine mod hepatitis B-virus	Inferred relationship	Some	4
difteri- + tetanus- + kighoste- + polio- + rekombinant hepatitis B-virus- + rekombinant Haemophilus influenzae type b-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	rekombinant vaccine mod hepatitis B-virus	Inferred relationship	Some	5
Haemophilus influenzae type b 7,5 µg + rekombinant hepatitis B-virusoverfladeantigen 5 µg injektionsvæske, opløsning, hætteglas a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	rekombinant vaccine mod hepatitis B-virus	Inferred relationship	Some	1
Haemophilus influenzae type b-vaccine 10 µg + difteritoxoid 30 IE + tetanustoxoid 40 IE + kighostevaccine 25 µg + rekombinant hepatitis B-virusoverfladeantigenvaccine 10 µg + inaktiveret poliovaccine injektionsvæske, opløsning 0,5 ml i fyldt sprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	rekombinant vaccine mod hepatitis B-virus	Inferred relationship	Some	6
rekombinant hepatitis B-virusoverfladeantigenvaccine 10 µg + difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulær kighostevaccine 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	rekombinant vaccine mod hepatitis B-virus	Inferred relationship	Some	1

Reference Sets

Concept inactivation indicator reference set

POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)